1 to 10 of 24 literature results

• A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B.

  BACKGROUND: Pegylated interferon (PEG-IFN)-alpha monotherapy is the current standard of care for short-term antiviral treatment of hepatitis B e antig…

  Authors: Paola Piccolo, Ilaria Lenci, Luigi Demelia, Franco Bandiera, Maria R Piras, Giorgio Antonucci, Lorenzo Nosotti, Terenzio Mari, Adriano De Santis, Maria L Ponti,…

  Source: Antiviral therapy. 2009

  View Full Text

• Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: significant clinical improvement during tamoxifen treatment.

  BACKGROUND/AIMS: Isolated liver angiomyolipomas (AMLs) occur in about 40% of TSC patients. Because of their slow growth, these tumors are often asympt…

  Authors: Ilaria Lenci, Mario Angelico, Giuseppe Tisone, Antonio Orlacchio, Giampiero Palmieri, Mariangela Pinci, Roberta Bombardieri, Paolo Curatolo

  Source: Journal of hepatology. 2008 Jun

  View Full Text

• A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.

  BACKGROUND/AIMS: We performed a randomized trial on pegylated interferon alfa-2a (Peg-IFNalpha) monotherapy vs Peg-IFNalpha and ribavirin in non-cirrh…

  Authors: Mario Angelico, Alessandra Petrolati, Raffaella Lionetti, Ilaria Lenci, Patrizia Burra, Maria Francesca Donato, Manuela Merli, Mario Strazzabosco, Giuseppe Tisone

  Source: Journal of hepatology. 2007 Jun

  View Full Text

• Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.

  BACKGROUND/AIMS: HCV-related disease recurrence progresses rapidly after liver transplantation. We hypothesised that withdrawal of immunosuppression m…

  Authors: Giuseppe Tisone, Giuseppe Orlando, Andrea Cardillo, Giampiero Palmieri, Tommaso Maria Manzia, Leonardo Baiocchi, Raffaella Lionetti, Alessandro Anselmo, Luca Toti, Mario Angelico

  Source: Journal of hepatology. 2006 Apr

  View Full Text

• Operational tolerance in clinical liver transplantation: emerging developments.

  There is still little understanding of the immune events that occur in transplant patients as they develop a relationship with their graft alloantigen…

  Authors: Giuseppe Tisone, Giuseppe Orlando, Mario Angelico

  Source: Transplant immunology. 2007 Feb

  View Full Text

• Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation.

  BACKGROUND: Cost of long-term prophylaxis with high-dose human hepatitis B immune globulin (HBIg) after liver transplantation is extremely high. The a…

  Authors: Daniele Di Paolo, Giuseppe Tisone, Paola Piccolo, Ilaria Lenci, Settimio Zazza, Mario Angelico

  Source: Transplantation. 2004 Apr 27

  View Full Text

• The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months.

  BACKGROUND: We report the update of the Tor Vergata immunosuppression (IS) weaning protocol in stable hepatitis C virus (HCV) liver transplant (LT) re…

  Authors: Giuseppe Orlando, Tommaso Manzia, Leonardo Baiocchi, Alberto Sanchez-Fueyo, Mario Angelico, Giuseppe Tisone

  Source: Transplant immunology. 2008 Nov

  View Full Text

• Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis C.

  OBJECTIVE: The objective of this study was to compare the efficacy of anti-hepatitis C virus (anti-HCV) treatment schedules on the basis of an early v…

  Authors: Mario Angelico, Beate Koehler-Horst, Paola Piccolo, Francesco Angelico, Silvia Gentile, Simona Francioso, Pierluigi Tarquini, Roberto Della Vecchia, Laura Ponti, Giampaolo Pilleri,…

  Source: European journal of gastroenterology & hepatology. 2008 Jul

  View Full Text

• Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience.

  The purpose of this study was to retrospectively determine the safety and effectiveness of percutaneous cryoablation, monitored with computed tomograp…

  Authors: Antonio Orlacchio, Gabriele Bazzocchi, Daniela Pastorelli, Francesca Bolacchi, Mario Angelico, Cristiana Almerighi, Salvatore Masala, Giovanni Simonetti

  Source: Cardiovascular and interventional radiology. 2008 May-Jun

  View Full Text

• Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats.

  BACKGROUND/AIMS: Taurohyodeoxycholate (THDCA) and tauroursodeoxycholate (TUDCA) induce more bile flow per molecule excreted compared to endogenous bil…

  Authors: Leonardo Baiocchi, Gianfranco Alpini, Shannon Glaser, Mario Angelico, Domenico Alvaro, Heather Francis, Marco Marzioni, Jo Lynne Phinizy, Barbara Barbaro, Gene LeSage

  Source: Journal of hepatology. 2003 Feb

  View Full Text